CPT® Code 87636

Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique

The CPT® Code 87636 refers to a diagnostic procedure that detects infectious agents through nucleic acid analysis, specifically targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for coronavirus disease (COVID-19), as well as influenza virus types A and B. This procedure employs a multiplex amplified probe technique, allowing for the simultaneous identification of multiple viral pathogens from a single sample. The method is particularly valuable in clinical settings where rapid and accurate diagnosis is crucial, especially given the overlapping symptoms of these respiratory illnesses. The multiplex approach enables healthcare providers to determine the presence of COVID-19 and influenza viruses concurrently, facilitating timely and appropriate treatment decisions. The underlying technology involves amplifying specific segments of viral DNA or RNA, which enhances the detection of even minimal amounts of genetic material. This is essential for accurate diagnosis, as respiratory samples may contain low viral loads. The procedure is performed on respiratory specimens collected from patients, ensuring that the testing process is both efficient and effective in identifying the causative agents of respiratory infections.